LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will hold an Analyst Event on Tuesday, March 25, 2008 from 8:00 a.m. - 12:00 p.m. (ET) at the St. Regis Hotel in New York. The program, “Oxidative Stress Induction: A Novel Mechanism to Treat Cancer,” will feature a series of presentations and a panel discussion by experts in the field of oxidative stress and melanoma.
